Treatment advances in myeloproliferative neoplasms: reports from the 56th American Society of Hematology annual meeting
10.3760/cma.j.issn.1009-9921.2015.04.001
- VernacularTitle:骨髓增殖性肿瘤治疗进展:第56届美国血液学会年会报道
- Author:
Luyang ZHANG
;
Danfeng ZHANG
;
Ling PAN
- Publication Type:Journal Article
- Keywords:
Myeloproliferative neoplasm;
Hydroxycarbamide;
Interferon;
JAK inhibitors;
Targeted treatment;
American Society of Hematology annual meeting
- From:
Journal of Leukemia & Lymphoma
2015;24(4):193-196,202
- CountryChina
- Language:Chinese
-
Abstract:
Great advances have been made in understanding the pathogenesis,diagnosis,risk stratification and treatment of classic bcr-abl-negative myeloproliferative neoplasms (MPN).This article reviews current situation in the treatment of these MPNs presented in the 56th American Society of Hematology (ASH) annual meeting.
